Abstract
Teicoplanin, a lipoglycopeptide antibiotic, consists of five major components (A2-1 through A2-5), one hydrolysis component (A3-1), and four minor components (RS-1 through RS-4). All the major components contain an N-acyl-beta-D-glucosamine, but they differ in the lengths and branchings of their acyl-aliphatic chains. Previous studies with radiolabeled teicoplanin in rats and humans have shown that the drug is eliminated by the renal route and that metabolic transformation is very minor, about 5%. A possible metabolic transformation of teicoplanin into A3-1 was also suggested. In the present study in humans, two metabolites (metabolites 1 and 2; 2 to 3% of total teicoplanin) were isolated after intravenous administration of radiolabeled teicoplanin. After purification, their structures were determined by fast atom bombardment mass spectroscopy and 1H nuclear magnetic resonance spectroscopy on the basis of the well-known correlations established in this field, and they were found to be new teicoplaninlike molecules, bearing 8-hydroxydecanoic and 9-hydroxydecanoic acyl moieties. This metabolic transformation is likely due to hydroxylation in the omega-2 and omega-1 positions for metabolites 1 and 2, respectively, of the C-10 linear side chain of component A2-3. This might explain the low extent of metabolism of teicoplanin if we consider that only component A2-3 has a linear chain that is susceptible to such oxidation.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bernareggi A., Cavenaghi L., Assandri A. Pharmacokinetics of [14C]teicoplanin in male rats after single intravenous dose. Antimicrob Agents Chemother. 1986 Nov;30(5):733–738. doi: 10.1128/aac.30.5.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bernareggi A., Danese A., Cometti A., Buniva G., Rowland M. Pharmacokinetics of individual components of teicoplanin in man. J Pharmacokinet Biopharm. 1990 Dec;18(6):525–543. doi: 10.1007/BF01073937. [DOI] [PubMed] [Google Scholar]
- Borghi A., Antonini P., Zanol M., Ferrari P., Zerilli L. F., Lancini G. C. Isolation and structure determination of two new analogs of teicoplanin, a glycopeptide antibiotic. J Antibiot (Tokyo) 1989 Mar;42(3):361–366. doi: 10.7164/antibiotics.42.361. [DOI] [PubMed] [Google Scholar]
- Borghi A., Coronelli C., Faniuolo L., Allievi G., Pallanza R., Gallo G. G. Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. IV. Separation and characterization of the components of teichomycin (teicoplanin). J Antibiot (Tokyo) 1984 Jun;37(6):615–620. doi: 10.7164/antibiotics.37.615. [DOI] [PubMed] [Google Scholar]
- Brown N., Ho D. H., Fong K. L., Bogerd L., Maksymiuk A., Bolivar R., Fainstein V., Bodey G. P. Effects of hepatic function on vancomycin clinical pharmacology. Antimicrob Agents Chemother. 1983 Apr;23(4):603–609. doi: 10.1128/aac.23.4.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Buniva G., Del Favero A., Bernareggi A., Patoia L., Palumbo R. Pharmacokinetics of 14C-teicoplanin in healthy volunteers. J Antimicrob Chemother. 1988 Jan;21 (Suppl A):23–28. doi: 10.1093/jac/21.suppl_a.23. [DOI] [PubMed] [Google Scholar]
- Cometti A., Gallo G. G., Kettenring J., Panzone G. B., Tuan G., Zerilli L. F. Isolation and structure determination of the main related substances of teicoplanin, a glycopeptide antibiotic. Farmaco Sci. 1988 Dec;43(12):1005–1018. [PubMed] [Google Scholar]
- Coronelli C., Gallo G. G., Cavalleri B. Teicoplanin: chemical, physico-chemical and biological aspects. Farmaco Sci. 1987 Oct;42(10):767–786. [PubMed] [Google Scholar]
- Matzke G. R., Zhanel G. G., Guay D. R. Clinical pharmacokinetics of vancomycin. Clin Pharmacokinet. 1986 Jul-Aug;11(4):257–282. doi: 10.2165/00003088-198611040-00001. [DOI] [PubMed] [Google Scholar]
- Riva E., Ferry N., Cometti A., Cuisinaud G., Gallo G. G., Sassard J. Determination of teicoplanin in human plasma and urine by affinity and reversed-phase high-performance liquid chromatography. J Chromatogr. 1987 Oct 9;421(1):99–110. doi: 10.1016/0378-4347(87)80383-3. [DOI] [PubMed] [Google Scholar]
- Rotschafer J. C., Crossley K., Zaske D. E., Mead K., Sawchuk R. J., Solem L. D. Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations. Antimicrob Agents Chemother. 1982 Sep;22(3):391–394. doi: 10.1128/aac.22.3.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zanolo G., Bernareggi A., Cavenaghi L., Giachetti C., Tognolo C. Distribution and excretion of teicoplanin in rats after single and repeated intravenous administration. Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:85–93. [PubMed] [Google Scholar]
- Zerilli L. F., Cavenaghi L., Bernareggi A., Assandri A. Teicoplanin metabolism in rats. Antimicrob Agents Chemother. 1989 Oct;33(10):1791–1794. doi: 10.1128/aac.33.10.1791. [DOI] [PMC free article] [PubMed] [Google Scholar]